Cargando…

New Drugs from Marine Organisms in Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Current approved drugs may only ameliorate symptoms in a restricted number of patients and for a restricted period of time. Currently, there is a translational research challenge into identifying the new effective drugs and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Patrizia, Kisialiou, Aliaksei, Lamonaca, Palma, Moroni, Rossana, Prinzi, Giulia, Fini, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728502/ https://www.ncbi.nlm.nih.gov/pubmed/26712769 http://dx.doi.org/10.3390/md14010005

Ejemplares similares

Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives
por: Lamonaca, Palma, et al.
Publicado: (2017)

Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds
por: Prinzi, Giulia, et al.
Publicado: (2018)

FKBP5 rs4713916: A Potential Genetic Predictor of Interindividual Different Response to Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease in a Real-Life Setting
por: Russo, Patrizia, et al.
Publicado: (2019)

Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]
por: Bonassi, Stefano, et al.
Publicado: (2018)

Deep sea as a source of novel-anticancer drugs: update on discovery and preclinical/clinical evaluation in a systems medicine perspective
por: Russo, Patrizia, et al.
Publicado: (2015)

Gene and protein expression of CXCR4 in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations
por: Neri, Monica, et al.
Publicado: (2018)

Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
por: Lamonaca, Giulia, et al.
Publicado: (2020)

Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents
por: Lima, Elisabete, et al.
Publicado: (2022)

Clinical evaluation of patients with moderate to severe Alzheimer disease
por: Varandas, Paulo Rogério Borges Rosmaninho, et al.
Publicado: (2007)

Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer’s Disease Therapeutic Agents
por: Llorach-Pares, Laura, et al.
Publicado: (2017)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases
por: Falco, Alberto, et al.
Publicado: (2022)

Exploitation of Marine Molecules to Manage Alzheimer’s Disease
por: Silva, Marisa, et al.
Publicado: (2021)

Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
por: Mourão, Paulo A. S.
Publicado: (2015)

Clinical trials of new drugs for Alzheimer disease
por: Huang, Li-Kai, et al.
Publicado: (2020)

Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases
por: Grosso, Clara, et al.
Publicado: (2014)

From smart grids to smart cities: new challenges in optimizing energy grids
por: Stecchi, U, et al.
Publicado: (2016)

Marine-Derived Compounds with Anti-Alzheimer’s Disease Activities
por: Hafez Ghoran, Salar, et al.
Publicado: (2021)

Effects of Field Simulated Marine Heatwaves on Sedimentary Organic Matter Quantity, Biochemical Composition, and Degradation Rates
por: Soru, Santina, et al.
Publicado: (2022)

New Perspectives on the Marine Carbon Cycle–The Marine Dissolved Organic Matter Reactivity Continuum
por: Gonsior, Michael, et al.
Publicado: (2022)

Consumer perception of attributes of organic food in Italy: A CUB model study
por: Lamonaca, Emilia, et al.
Publicado: (2022)

Marine Drugs -A New International Journal
por: Lin, Shu-Kun, et al.
Publicado: (2003)

The role of resilience and coping among Italian healthcare workers during the COVID-19 pandemic
por: Marcolongo, Federica, et al.
Publicado: (2021)

New drug discovery for Alzheimer's disease: Challenges and hopes
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2009)

Back to The Fusion: Mitofusin-2 in Alzheimer’s Disease
por: Sita, Giulia, et al.
Publicado: (2020)

Alzheimer’s Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore
por: Botelho, Maria João, et al.
Publicado: (2022)

Fertility drugs, reproductive strategies and ovarian cancer risk
por: Tomao, Federica, et al.
Publicado: (2014)

Marine Natural Products: A Way to New Drugs
por: Stonik, V.A.
Publicado: (2009)

Exploring the ocean for new drug developments: Marine pharmacology
por: Malve, Harshad
Publicado: (2016)

Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease
por: Martins, Márcia, et al.
Publicado: (2020)

LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer’s and Parkinson’s Disease-Related Neuroinflammation
por: Mutti, Veronica, et al.
Publicado: (2023)

The Journal Marine Drugs and the First International Symposium on Marine Drugs (2004)
por: Guan, Hua-Shi
Publicado: (2003)

P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease
por: Sita, Giulia, et al.
Publicado: (2017)

Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery
por: Lee, Jin-Young, et al.
Publicado: (2015)

Bioaccumulation of cadmium in marine organisms.
por: Frazier, J M
Publicado: (1979)

Chemical Defense in Marine Organisms
por: Lauritano, Chiara, et al.
Publicado: (2020)

Metabolomics on the study of marine organisms
por: Bayona, Lina M., et al.
Publicado: (2022)

New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
por: Hölscher, Christian
Publicado: (2014)

Calcium Dysregulation in Alzheimer’s Disease: A Target for New Drug Development
por: Wang, Yong, et al.
Publicado: (2017)

New Insights into Alzheimer’s Disease: Novel Pathogenesis, Drug Target and Delivery
por: Chen, Haishu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_livsknco6tn7t616i1td1e2vpb